Heterocyclic arylsulfonamidobenzylic compounds are provided which are useful in treating lipid disorders, metabolic disorders and cell-proliferative diseases.

 
Web www.patentalert.com

< N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use

< Substituted phenylpropionic acid derivatives

> Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons

> OB fusion protein compositions and methods
~ 00288